Trial intelligence / Profile preview

Thyrogen vs Hypothyroid State for Thyroid Remnant Ablation

NCT00196729Phase 3Completed

Sponsor
Sanofi
Start
Dec 2001
Modality
Biologic, rProtein (Recombinant Protein), Hormone
01

Overview

A Phase 3 trial of thyrotropin alfa in differentiated thyroid cancer (DTC), sponsored by Sanofi. Started Dec 2001; status: completed.

02

Drugs

thyrotropin alfa
03

Conditions

differentiated thyroid cancer (DTC)

Beyond the preview

Go deeper on NCT00196729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00196729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call